NEW YORK (GenomeWeb News) — Third Wave Technologies today said second-quarter revenues grew 9 percent as R&D spending rose 73 percent and net loss widened 53 percent.  
 
Total receipts for the three months ended June 30 increased to $7.4 million from $6.8 million year over year.
 
Revenue from clinical products rose 26 percent to $6.3 million, while receipts from research products tumbled 37 percent to $1.1 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.